Supernus Pharmaceuticals | SUPN - 股票

股票价格

50.68

每天变化

-0.82 -1.59%

每月一次

-4.77%

每年

60.03%

Q2 预测

49.30

金融业

USD

USD 1.45B

现金及等价物

USD 151.37M

USD 47.53M

USD 644.18M

USD 338.17M

USD 42.21M

USD 13.82M

USD 48.5M

674

EPS每股收益

USD -0.07

股本和储备

USD 1.06B

USD 164.04M

债务利息支出

USD 910K

USD 2.28M

USD 400.38M

USD 2.85B

USD -45.12M

USD 197.75M

USD 13.82M

普通股股本

USD 57.12M

110.38

USD -1.91M

USD 211.6M

销售和管理费用

USD 122.39M

USD 107.1M

贸易债权人

USD 107.8M

应收帐款人

USD 187.8M

	股票	更改		日
Abbott	USD 6.49B		220M	2025-12
ANI Pharmaceuticals	USD 143.07M		3.41M	2025-12
Aurora Cannabis	CAD 230.56M		8.6M	2025-12
Bristol-Myers Squibb	USD 2.76B		21M	2025-09
Canopy Growth	CAD 105.56M		3.18M	2025-12
Cara Therapeutics	USD 900K		0	2025-03
Corcept Therapeutics	USD 12.87M		519K	2025-12
Eisai	JPY 236.46B		9.14B	2025-09
Eli Lilly	USD 13.74B		1.56B	2025-12
Novo Nordisk	DKK 45.65B		21.26B	2025-06
Pacira	USD 152.86M		4.82M	2025-12
Perrigo	USD 1.15B		78M	2025-12
Pfizer	USD 11.47B		201M	2025-09
Supernus Pharmaceuticals	USD 107.1M		63.08M	2025-09
United Therapeutics	USD 183.1M		6.6M	2025-12
Xeris Pharmaceuticals	USD 68.67M		1.21M	2025-12